 |
PDBsum entry 2flr
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/blood clotting
|
PDB id
|
|
|
|
2flr
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
96 a.a.
|
 |
|
|
|
|
|
|
|
254 a.a.
|
 |
|
|
|
|
|
|
|
151 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Novel 5-Azaindole factor viia inhibitors.
|
 |
|
Authors
|
 |
J.R.Riggs,
H.Hu,
A.Kolesnikov,
E.M.Leahy,
K.E.Wesson,
W.D.Shrader,
D.Vijaykumar,
T.A.Wahl,
Z.Tong,
P.A.Sprengeler,
M.J.Green,
C.Yu,
B.A.Katz,
E.Sanford,
M.Nguyen,
R.Cabuslay,
W.B.Young.
|
 |
|
Ref.
|
 |
Bioorg Med Chem Lett, 2006,
16,
3197-3200.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
The discovery and development of 5-azaindole factor VIIa inhibitors will be
described.
|
 |
|
|
|
|
 |